RxDoctor Payments Data

Ambrose Panico, DO

Clinical Cardiac Electrophysiology · Mesa, AZNPI 1245539659

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (35.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 44 manufacturers reported payments, led by Impulse Dynamics (USA) Inc. at 30.3% of the total. Among clinical cardiac electrophysiology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$107,755in general payments, 2019–2025

Across 707 payments — averaging $152.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Impulse Dynamics (USA) Inc.$33K
  • Biosense Webster, Inc.$19K
  • Sanofi-aventis U.S. LLC$14K
  • Medtronic$12K
  • Boston Scientific$11K
  • Abbott$8K
  • plus $11K from 38 others
$254,902in research payments, 2019–2025

Across 148 payments — averaging $1722.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Impulse Dynamics (USA) Inc.$219K
  • Medtronic$36K

What the payments were for

  • Consulting fees$15,50014%
  • Speaking & faculty fees$38,35236%
  • Grants$12,65012%
  • Travel & lodging$10,1009%
  • Food & beverage$30,70228%
  • Education$4110%
  • Other$390%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$107,755 in reported general payments places this provider in the 90th percentile of 80 clinical cardiac electrophysiology providers in Arizona.

See all clinical cardiac electrophysiology providers in Arizona

Medicare billing

Part B allowed, 2024
$688,176
Medicare patients
1,238
Services billed
8,225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban491$584,297
XareltoRivaroxaban139$179,559
EntrestoSacubitril/Valsartan85$112,561
MultaqDronedarone Hcl59$76,279
FarxigaDapagliflozin Propanediol31$35,938
CorlanorIvabradine Hcl28$15,636
Flecainide Acetate103$5,821
SotalolSotalol Hcl170$4,978
Amiodarone Hcl122$4,187
Dofetilide13$3,286
Metoprolol Succinate234$3,114
Sucralfate34$2,419
PaceroneAmiodarone Hcl11$1,920
Diltiazem 24hr Er (Cd)Diltiazem Hcl55$1,542
Carvedilol122$1,446

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$157$584,297491 claims
Johnson & JohnsonXarelto$27$179,559139 claims
NovartisEntresto$168$112,56185 claims
Sanofi-aventis U.S. LLCMultaq$14,162$76,27959 claims
AmgenCorlanor$720$15,63628 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 80 clinical cardiac electrophysiology providers in Arizona.

Other clinical cardiac electrophysiology in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →